Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material:
SEC Accession No. 0001193125-25-035283
Filing Date
2025-02-25
Accepted
2025-02-25 17:21:26
Documents
13

Document Format Files

Seq Description Document Type Size
1 DFAN14A d925868ddfan14a.htm DFAN14A 24297
2 GRAPHIC g925868txp10g1.jpg GRAPHIC 72252
3 GRAPHIC g925868txp11g1.jpg GRAPHIC 278353
4 GRAPHIC g925868txp12g1.jpg GRAPHIC 202988
5 GRAPHIC g925868txp13g1.jpg GRAPHIC 172825
6 GRAPHIC g925868txp2g1.jpg GRAPHIC 504046
7 GRAPHIC g925868txp3g1.jpg GRAPHIC 470676
8 GRAPHIC g925868txp4g1.jpg GRAPHIC 285579
9 GRAPHIC g925868txp5g1.jpg GRAPHIC 149905
10 GRAPHIC g925868txp6g1.jpg GRAPHIC 419338
11 GRAPHIC g925868txp7g1.jpg GRAPHIC 242199
12 GRAPHIC g925868txp8g1.jpg GRAPHIC 280597
13 GRAPHIC g925868txp9g1.jpg GRAPHIC 346338
  Complete submission text file 0001193125-25-035283.txt   4744781
Mailing Address ONE JOHNSON & JOHNSON PLZ NEW BRUNSWICK NJ 08933
Business Address ONE JOHNSON & JOHNSON PLZ NEW BRUNSWICK NJ 08933 732-524-2455
JOHNSON & JOHNSON (Filed by) CIK: 0000200406 (see all company filings)

EIN.: 221024240 | State of Incorp.: NJ | Fiscal Year End: 1229
Type: DFAN14A
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 135 ROUTE 202/206 SUITE 6 BEDMINSTER NJ 07921
Business Address 135 ROUTE 202/206 SUITE 6 BEDMINSTER NJ 07921 (646) 440-9333
Intra-Cellular Therapies, Inc. (Subject) CIK: 0001567514 (see all company filings)

EIN.: 364742850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DFAN14A | Act: 34 | File No.: 001-36274 | Film No.: 25664977
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)